BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18245010)

  • 21. Conventional and novel PET tracers for imaging in oncology in the era of molecular therapy.
    Pantaleo MA; Nannini M; Maleddu A; Fanti S; Ambrosini V; Nanni C; Boschi S; Biasco G
    Cancer Treat Rev; 2008 Apr; 34(2):103-21. PubMed ID: 18055120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Current applications of PET/CT].
    Soussan M; Pop G; Eder V
    Rev Prat; 2013 Nov; 63(9):1199-207. PubMed ID: 24422285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How to assess anti-tumour efficacy by imaging techniques.
    Gwyther SJ; Schwartz LH
    Eur J Cancer; 2008 Jan; 44(1):39-45. PubMed ID: 18060765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of molecular imaging in drug discovery and development.
    Hargreaves RJ
    Clin Pharmacol Ther; 2008 Feb; 83(2):349-53. PubMed ID: 18167503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New techniques in the pharmacokinetic analysis of cancer drugs. IV. Positron emission tomography.
    Tilsley DW; Harte RJ; Jones T; Brady F; Luthra SK; Brown G; Price PM
    Cancer Surv; 1993; 17():425-42. PubMed ID: 8137352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unexplored pharmacokinetic opportunities with microdosing in oncology.
    Sparreboom A
    Clin Cancer Res; 2007 Jul; 13(14):4033-4. PubMed ID: 17634525
    [No Abstract]   [Full Text] [Related]  

  • 27. Integrated PET-CT: evidence-based review of oncology indications.
    Sachelarie I; Kerr K; Ghesani M; Blum RH
    Oncology (Williston Park); 2005 Apr; 19(4):481-90; discussion 490-2, 495-6. PubMed ID: 15934517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PET-CT scan in pediatric oncology: where, when, how and at what price?
    Arora B; Parikh PM
    Indian J Cancer; 2010; 47(4):355-9. PubMed ID: 21131746
    [No Abstract]   [Full Text] [Related]  

  • 29. Establishing a PET/CT practice.
    Shreve P
    AJR Am J Roentgenol; 2005 May; 184(5 Suppl):S146-51. PubMed ID: 15855083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Positron emission tomography: foundations and applications].
    Gulyás B; Trón L; Csiba L; Esik O; Pálinkás J; Szabó Z
    Orv Hetil; 1996 Apr; 137(14):731-8. PubMed ID: 8927318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positron emission tomography for use in microdosing studies.
    Wagner CC; Müller M; Lappin G; Langer O
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):104-10. PubMed ID: 18175273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [PET as a tool in pharmacologic development].
    Bergström M; Hartvig P; Långström B
    Nord Med; 1998 Sep; 113(7):226-9. PubMed ID: 9755618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PET/CT in radiation oncology.
    Pan T; Mawlawi O
    Med Phys; 2008 Nov; 35(11):4955-66. PubMed ID: 19070229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cancer chemotherapy; past, present and future--from the aspect of fundamental studies].
    Tukagoshi S
    Gan To Kagaku Ryoho; 2003 Oct; 30(10):1398-403. PubMed ID: 14584271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical application of computed x ray tomography in tumour identification.
    Conry BG; Reznek RH
    Cancer Surv; 1987; 6(2):379-96. PubMed ID: 3322553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [CT-PET and evaluation of therapy response. is the size really important?].
    Fernández A; Duch J; Flotats A; Camacho V; Estorch M; Carrió I
    Rev Esp Med Nucl; 2010; 29(4):184-8. PubMed ID: 20638956
    [No Abstract]   [Full Text] [Related]  

  • 37. Whole-body imaging with MRI or PET/CT: the future for single-modality imaging in oncology?
    Blomqvist L; Torkzad MR
    JAMA; 2003 Dec; 290(24):3248-9. PubMed ID: 14693879
    [No Abstract]   [Full Text] [Related]  

  • 38. [Microdose clinical trial--impact of PET molecular imaging].
    Yano T; Watanabe Y
    Gan To Kagaku Ryoho; 2010 Oct; 37(10):1839-48. PubMed ID: 20948244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Realizing the full potential of PET for measuring the biodistribution of novel anticancer agents.
    Jones T; Price P; Tavitian B
    J Nucl Med; 2011 Sep; 52(9):1500. PubMed ID: 21824989
    [No Abstract]   [Full Text] [Related]  

  • 40. [PET/CT 16-multislice: an anatomo functional view of the heart].
    Alexánderson E; Romero Ibarra JL; Ricalde A; Meave A
    Arch Cardiol Mex; 2005; 75(1):86-9. PubMed ID: 15909746
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.